Qtrex Quantum Ltd

Qtrex Quantum Ltd(QTEX)股票分析

$1.290

-0.093 (-7.19%)收盤時

Loading chart…
最高
1.380
開盤
1.360
成交量加權均價
1.30
成交量
5.28M
市值
—
最低
1.220
成交金額
6.84M
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

AI 分析 of Qtrex Quantum Ltd (QTEX)

持有

QTEX is currently trading at $1.39 with a forward P/E of 8.25, indicating potential value, but the RSI is at 44.073, suggesting it is not yet oversold. The stock has experienced a significant year-to-date change of +265.79%, but it has recently declined by 7.33% over the last five days, indicating volatility. The main risk is the negative EPS forecast for Q4 2024 at -0.60, which could impact investor sentiment.

估值指標

Qtrex Quantum Ltd(QTEX)目前預期本益比為 8.25,5 年平均預期本益比為 12.21。

預期本益比

合理
5 年均值 P/E
12.21
目前P/E
8.25
高估
18.10
低估
6.31

預期 EV/EBITDA

5 年均值 EV/EBITDA
目前EV/EBITDA
0.00

預期股價營收比

5 年均值 P/S
目前P/S
0.00

事件時間軸

2026-10-09 (ET)

17:00:00

Qtrex Quantum Receives Nasdaq Warning

2026-10-01 (ET)

09:00:00

QTREX Quantum Announces AME Cryogenic Interconnect Testing Results

2026-09-24 (ET)

09:00:00

QTREX Reports 1H Revenue of $1.55M

09:00:00

Company Expects Q4 2026 to Be Its Most Active Commercial Period

2026-08-26 (ET)

16:00:00

D-Wave Quantum CFO Markovich Retires, Greg Golkov Takes Over

資訊

QTEX 常見問題 —— 由 Alphio AI 解答

Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV. It operates in the Healthcare sector.

QTEX is currently trading at $1.39 with a forward P/E of 8.25, indicating potential value, but the RSI is at 44.073, suggesting it is not yet oversold. The stock has experienced a significant year-to-date change of +265.79%, but it has recently declined by 7.33% over the last five days, indicating volatility. The main risk is the negative EPS forecast for Q4 2024 at -0.60, which could impact investor sentiment.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易